Metabolic health is a more important determinant for diabetes development than simple obesity: A 4-year retrospective longitudinal study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Rhee, Eun Jung ^a   Lee, Min Kyung ^a   Kim, Jong Dae ^a   Jeon, Won Seon ^a   Bae, Ji Cheol ^a   Park, Se Eun ^a   Park, Cheol Young ^a   Oh, Ki Won ^a   Park, Sung Woo ^a   Lee, Won Young ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC HEALTH; METABOLISM; OBESITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ANALYSIS OF VARIANCE; ANTHROPOMETRY; COMPLICATION; DIABETES MELLITUS, TYPE 2; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOALPHALIPOPROTEINEMIA; INSULIN RESISTANCE; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; SOUTH KOREA;

ADULT; ANALYSIS OF VARIANCE; ANTHROPOMETRY; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOALPHALIPOPROTEINEMIAS; INSULIN RESISTANCE; LONGITUDINAL STUDIES; OBESITY; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84901608827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098369     Document Type: Article

References (28)

1. Galic S, Oakhill JS, Steinberg GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316:129-139.
2. McLaughlin T, Lamendola C, Liu A, Abbasi F (2011) Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 96:E1756-E1760.
3. Yu JH, Yim SH, Yu SH, Lee JY, Kim JD, et al. (2013) The Relationship of Body Composition and Coronary Artery Calcification in Apparently Healthy Korean Adults. Endocrinol Metab. 28:33-40.
4. Blüher M (2012) Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 19:341-346.
5. Hamer M, Stamatakis E (2012) Metabolically healthy obesity and risk of allcause and cardiovascular disease mortality. J Clin Endocrinol Metab 97:2482-2488.
6. Calori G, Lattuada G, Piemonti LGarancini MP, Ragogna F, et al. (2011) Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34:210-215.
7. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, et al. (2013) Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 36:2388-2394.
8. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriat Soc 50:889-896. (Pubitemid 34496687)
9. List of NGSP Certified Methods. Available at http://www.ngsp.org/docs/ methods.pdf. Lastly accessed 2012 November 26
10. Schwartz KL, Monsur JC, Bartoces MG, West PA, Neale AV (2005) Correlation of same-visit HbA1c test with laboratory-based measurements: a MetroNet study. BMC Fam Pract 6:28.
11. American Diabetes Association (2013) Standards of medical care in diabetes - 2013. Diabetes Care 36 Suppl 1:S11-S66.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289:2560-2572. (Pubitemid 37430158)
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419. (Pubitemid 15018832)
14. Steering Committee of the WHO Western Pacific Region, IASO & IOTF (2000) The Asia-Pacific perspective: redefining obesity and its treatment, Australia.
15. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, et al. (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168:1617-1624.
16. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Force on epidemiology and prevention; National heart, Lung, and blood Institute; American heart association; World heart Federation; International atherosclerosis Society; and International association for the study of obesity. Circulation 120:1640e5.
17. Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR (2012) Insulin-sensitive obesity in humans - a 'favorable fat' phenotype? Trends Endocrinol Metab 23:116-124.
18. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, et al. (2013) The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 34:389-397.
19. Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, et al. (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299:E506-E515.
20. Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, et al. (2013) Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One 8:e76188
21. Seo MH, Bae JC, Park SE, Rhee EJ, Park CY, et al. (2011) Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study. J Clin Endocrinol Metab 96:E2050-E2054.
22. Alqahtani N, Khan WA, Alhumaidi MH, Ahmed YA (2013) Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre-diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test. Int J Prev Med 4:1025-1029.
23. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P (2013) Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 64:1043-1051.
24. Majka DS, Chang RW, Vu TH, Palmas W, Geffken DF, et al. (2009) Physical activity and high-sensitivity C-reactive protein: the multi-ethnic study of atherosclerosis. Am J Prev Med 36:56-62.
25. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H (1999) Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - A population-based twin study. Diabetologia 42:139-145. (Pubitemid 29064234)
26. North KE, Williams JT, Welty TK, Best LG, Lee ET, et al. (2003) Evidence for joint action of genes on diabetes status and CVD risk factors in American Indians: The strong heart family study. Int J Obes Relat Metab Disord 27:491-497. (Pubitemid 36520849)
27. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885.
28. Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, et al. (2013) Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 36:2294-2300.